Anxiety and depression in opiate addicts treated with methadone and buprenorphine

Objective: To examine anxiety and depression in opiate addicts treated with methadone and buprenorphine. Subjects and methods: The study was conducted in the Association \u27Margina\u27 and the Center for Prevention and Out-patient Treatment of Addiction Diseases in Mostar. It included 100 patients who were divided into two groups: the first group consisted of drug subox- on users (N=50) and the other group consisted of subjects addicted to methadone, which was divided into two subgroups: M+ and M– (recurrent). For the purposes of the research, Beck \u27s Anxiety and Depression Scale, Selfassessment Questionnaire for Anxiety (STAI), socio-demographic questionnaire specifically made for this research and Health Survey SF -36 (Short – Form Health Survey – 36th) were used. Results: Significantly higher numbers of addicts were living in the city (p = 0.034). The recurrent methadone users were significantly more depressed (> 20 %), while this percentage was somewhat lower in SBX users and M + subjects (20%). There was no statistically significant difference between the latter two groups (p=0.216). SBX users displayed most anxiety (10 %), while it was lowest among the users of methadone (